Personalized Retail Nutrition & Wellness Market by Product Type (Fitness Trackers, Meal Services, Nutrigenomics Tests), Sales Model (One-time Purchase, Pay-per-use, Subscription), Distribution Channel, End-user - Global Forecast 2025-2032
Description
The Personalized Retail Nutrition & Wellness Market was valued at USD 12.37 billion in 2024 and is projected to grow to USD 14.29 billion in 2025, with a CAGR of 16.14%, reaching USD 40.96 billion by 2032.
A strategic introduction to how individualized nutrition and wellness solutions are transforming retail experiences through data, science, and consumer expectations
The personalized retail nutrition and wellness landscape is converging technological innovation, individualized health science, and evolving consumer expectations. Across retail touchpoints and care channels, personalization is transitioning from a niche differentiator to a mainstream expectation, driven by data-enabled interactions and a heightened focus on outcomes. As consumers seek solutions that align with their lifestyles and health objectives, product and service ecosystems are adapting to meet needs for convenience, clarity, and clinically informed personalization.
Today’s retailers and wellness providers face a dual mandate: deliver seamless digital experiences while ensuring clinical credibility and regulatory compliance. Technology platforms and consumer-facing services are increasingly integrated, enabling richer intake assessments, real-time behavioral nudges, and adaptive product recommendations. Meanwhile, stakeholder alignment across supply chain partners, clinical advisors, and retail operators is critical to translate individualized insights into reliable, scalable offerings. Transitioning from pilot projects to sustainable business models requires a disciplined approach to data governance, product portfolio strategy, and experience design.
In sum, the market’s trajectory reflects a deeper commitment to personalization that balances scientific integrity, commercial viability, and consumer empowerment. Organizations that recognize these dynamics and act to bridge clinical insight with retail execution will unlock differentiated value and stronger long-term consumer relationships.
Key transformative shifts in technology adoption, regulatory expectations, and omnichannel retail that are redefining personalized nutrition and wellness delivery
The landscape of personalized retail nutrition and wellness is being reshaped by several transformative shifts that extend across technology, consumer behavior, regulation, and distribution. Advances in digital health capabilities-ranging from wearable sensing to cloud-native analytics-are enabling richer, continuous streams of consumer data, which in turn support more precise, contextualized recommendations and adaptive product formulations. Concurrently, consumers are demonstrating higher expectations for transparency, ethical sourcing, and clinically grounded claims, prompting brands to invest in verifiable evidence and clearer communication.
Regulatory scrutiny and evolving standards for health-related claims are also prompting strategic recalibrations. Firms are prioritizing compliance pathways, scientific partnerships, and robust labeling practices to maintain consumer trust while minimizing legal and reputational risk. Distribution is fragmenting and converging at once: direct-to-consumer digital channels are coexisting with traditional retail footprints and health care integration, creating hybrid models that emphasize convenience, professional oversight, and omnichannel fulfillment.
Taken together, these shifts create both opportunity and complexity. Companies that can operationalize data responsibly, demonstrate clinical validity, and orchestrate omnichannel distribution will be better positioned to scale personalized offerings in a way that delivers meaningful health outcomes and durable commercial returns.
How the cumulative effects of recent United States tariff changes are reshaping sourcing, supply chain resilience, and product strategy across personalized wellness offerings
Recent tariff developments in the United States have introduced a compound set of operational, sourcing, and pricing considerations for companies engaged in personalized retail nutrition and wellness. Tariff adjustments affecting imported ingredients, finished supplements, and certain electronic components used in fitness trackers and diagnostic devices have increased the complexity of global supply decisions. As a result, many organizations are reassessing supplier footprints, inventory strategies, and regional manufacturing options to mitigate cost volatility and preserve margin integrity.
Beyond direct cost implications, tariff measures have ripple effects on product formulation choices and the sourcing of clinically validated inputs. Procurement teams are evaluating domestic and nearshore suppliers to reduce exposure to trade disruptions, while product development functions are prioritizing ingredient flexibility to enable rapid substitution when necessary. Logistics and lead-time management have become central to commercial planning, with inventory buffers and alternative routing options incorporated to maintain service levels for subscription and replenishment models.
In addition, tariffs are accelerating strategic conversations about vertical integration and partnerships. Companies with trading agility and diversified sourcing are better able to sustain retail price stability and preserve customer trust. Ultimately, the cumulative impact of tariff shifts underscores the need for dynamic supply strategies, closer supplier relationships, and scenario-based planning to ensure continuity of personalized offerings in a rapidly changing trade environment.
Detailed segmentation insights that connect product typologies, distribution pathways, sales models, and diverse end-user cohorts to inform targeted commercial strategies
Segmentation insights reveal distinct demand signals and operational priorities across the product, distribution, sales, and end-user dimensions that define the personalized nutrition and wellness landscape. By product type, offerings range from fitness trackers that capture behavioral and physiological signals to meal services that deliver convenience and dietary adherence; nutrigenomics tests that translate genetic markers into tailored dietary guidance; nutritional counseling that connects clinical expertise with behavior change strategies; and supplements offered in capsules, liquids, and powders that address concentrated nutritional needs. Each product category carries different validation requirements, packaging needs, and return-to-consumer workflows, which influence go-to-market planning and customer onboarding.
Distribution patterns are equally varied, spanning online retailers that enable personalized configuration and recurring fulfillment; pharmacies and drug stores that offer healthcare-adjacent credibility and point-of-care accessibility; specialty stores that curate targeted assortments; and supermarkets and hypermarkets that deliver scale and impulse accessibility. The chosen channel affects discovery mechanics, promotional cadence, and fulfillment complexity, and therefore must align with the product’s evidence requirements and consumer expectations.
Sales models further differentiate revenue lifecycles and engagement intensity, encompassing one-time purchases for discrete products, pay-per-use arrangements for on-demand testing or services, and subscriptions that support ongoing adherence and replenishment. Finally, end-user segmentation spans fitness centers that value integration with coaching and class experiences, healthcare and wellness centers that emphasize clinical oversight, and individual consumers whose needs cluster around general wellness, sports nutrition, or weight management. Understanding these intersecting segments enables precise positioning, tailored service design, and investment prioritization across product development and channel partnerships.
Region-specific strategic considerations for scaling personalized nutrition and wellness offerings across Americas, Europe, Middle East & Africa, and Asia-Pacific markets
Regional dynamics exert a powerful influence on product adoption, regulatory posture, and partnership opportunities across the global personalized nutrition and wellness ecosystem. In the Americas, consumer appetite for convenience and evidence-based personalization is high, allied with a sophisticated digital payments and fulfillment infrastructure that supports subscription and direct-to-consumer models. Regulatory and reimbursement pathways are complex and vary by jurisdiction, prompting firms to adopt phased rollouts and localized clinical validation approaches.
In Europe, the Middle East & Africa, harmonized regulatory frameworks across many European markets and high consumer expectations for sustainability and ethical sourcing shape product claims and packaging choices. Meanwhile, emerging markets across the region present growth opportunities driven by rising health awareness and increasing investment in retail infrastructure, but they require tailored pricing strategies and culturally relevant product formulations. Supply chain resilience and compliance with cross-border data rules are important considerations for companies planning multi-country deployments.
Across Asia-Pacific, rapid digital adoption and a strong retail technology ecosystem enable fast consumer feedback loops and agile personalization features. Markets in this region often combine high receptivity to nutraceuticals and wellness services with distinct local ingredient preferences and regulatory regimes. Strategic partnerships with regional distributors and local clinical partners can accelerate acceptance and ensure that offerings align with both consumer tastes and regulatory expectations. Across all regions, successful entrants balance global best practices with rigorous local adaptation.
Competitive and partnership dynamics that drive differentiation through clinical validation, data capabilities, and integrated retail-to-care execution across the ecosystem
Competitive dynamics in personalized retail nutrition and wellness are shaped by a mix of specialty innovators, established consumer brands extending into personalization, and service providers that bridge clinical expertise with retail execution. Leading players differentiate through proprietary data assets, clinically validated algorithms, and tightly managed supply chains that ensure product consistency and trust. Strategic partnerships between technology providers and clinical institutions are becoming more common, enabling faster evidence generation and enhanced credibility for consumer-facing claims.
Mergers and alliances are also reshaping capability sets, with companies seeking to combine diagnostic insights, behavioral engagement platforms, and distribution reach in order to offer end-to-end personalized solutions. At the same time, niche specialists continue to command attention by focusing on specific use cases-such as athletic performance, metabolic health, or age-related nutrition-where deep domain expertise and targeted formulations deliver measurable benefits. Operational excellence in regulatory compliance, data privacy, and quality control remains a sustained differentiator, particularly as scrutiny on health claims intensifies.
In this competitive environment, incumbents that pair robust clinical validation with seamless retail experiences will sustain consumer trust and long-term engagement, while new entrants that can move quickly to demonstrate efficacy and differentiate through service integration will capture emerging segments of demand.
Actionable recommendations for leaders to align clinical validation, supply resilience, and omnichannel execution for scalable personalized nutrition and wellness offerings
Industry leaders seeking to capture value in personalized retail nutrition and wellness should prioritize a set of actionable initiatives that align clinical rigor with commercial execution. First, invest in modular product architectures and ingredient sourcing flexibility to enable rapid adaptation to supply disruptions and regulatory shifts. Second, establish partnerships with accredited clinical and research institutions to strengthen evidence generation and to support transparent consumer communication about efficacy and safety. Third, design omnichannel fulfillment pathways that maintain consistent consumer experiences across online, pharmacy, specialty, and supermarket touchpoints while optimizing for customer lifetime engagement.
Additionally, build data governance frameworks that ensure privacy, interoperability, and analytic integrity so that personalization algorithms can be validated and audited. Operationalize subscription and replenishment models with frictionless onboarding and clearly communicated outcomes to minimize churn and maximize adherence. Finally, allocate resources to scenario-based supply chain planning and tariff impact mitigation, embracing nearshoring and multi-sourcing strategies where appropriate to preserve margin and continuity. Taken together, these actions will strengthen resilience, accelerate adoption, and enhance the credibility of personalized offerings in a competitive landscape.
Transparent research methodology combining interviews, clinical literature review, regulatory analysis, and operational scenario assessment to validate actionable insights
The research approach integrates qualitative and quantitative evidence streams to produce an evidence-informed synthesis of industry dynamics, consumer behavior, and operational considerations. Primary engagements include structured interviews with industry executives, clinical advisers, and distribution partners to capture firsthand perspectives on adoption barriers, pricing sensitivities, and channel economics. Secondary inputs encompass peer-reviewed clinical literature, product labeling and regulatory guidance, patent filings, and publicly available company disclosures to triangulate technical claims and capability sets.
Analytical steps emphasize cross-validation and scenario analysis: findings from interviews are compared with published clinical evidence and regulatory documentation to assess claim robustness, while supply chain observations are mapped against trade data and logistics indicators to evaluate resilience. Where applicable, case studies illustrate how different business models-such as subscription versus one-time purchase-affect customer retention and fulfillment complexity. Transparency in source attribution and methodological limitations is maintained throughout the research so that readers can understand evidence strength and boundary conditions for the insights provided.
Concluding synthesis emphasizing the necessity of clinical credibility, supply resilience, and omnichannel execution to realize personalization-driven value in retail wellness
The personalized retail nutrition and wellness domain sits at an intersection of science, retail, and consumer behavior, presenting substantial opportunity alongside operational complexity. Organizations that successfully bridge clinical validation with frictionless retail experiences will build durable consumer trust and sustained engagement. Conversely, those that underinvest in evidence, data governance, or supply resilience risk reputational exposure and commercialization friction.
Looking ahead, success will hinge on the ability to integrate multidimensional capabilities-robust ingredient supply networks, validated personalization algorithms, trusted clinical partnerships, and seamless omnichannel fulfillment. Companies that adopt flexible product architectures, prioritize transparent claims supported by clinical input, and design subscription and replenishment mechanics for adherence will be best positioned to meet evolving consumer expectations. The path to durable growth depends not only on innovation, but on disciplined execution across regulatory, operational, and customer-experience domains.
Please Note: PDF & Excel + Online Access - 1 Year
A strategic introduction to how individualized nutrition and wellness solutions are transforming retail experiences through data, science, and consumer expectations
The personalized retail nutrition and wellness landscape is converging technological innovation, individualized health science, and evolving consumer expectations. Across retail touchpoints and care channels, personalization is transitioning from a niche differentiator to a mainstream expectation, driven by data-enabled interactions and a heightened focus on outcomes. As consumers seek solutions that align with their lifestyles and health objectives, product and service ecosystems are adapting to meet needs for convenience, clarity, and clinically informed personalization.
Today’s retailers and wellness providers face a dual mandate: deliver seamless digital experiences while ensuring clinical credibility and regulatory compliance. Technology platforms and consumer-facing services are increasingly integrated, enabling richer intake assessments, real-time behavioral nudges, and adaptive product recommendations. Meanwhile, stakeholder alignment across supply chain partners, clinical advisors, and retail operators is critical to translate individualized insights into reliable, scalable offerings. Transitioning from pilot projects to sustainable business models requires a disciplined approach to data governance, product portfolio strategy, and experience design.
In sum, the market’s trajectory reflects a deeper commitment to personalization that balances scientific integrity, commercial viability, and consumer empowerment. Organizations that recognize these dynamics and act to bridge clinical insight with retail execution will unlock differentiated value and stronger long-term consumer relationships.
Key transformative shifts in technology adoption, regulatory expectations, and omnichannel retail that are redefining personalized nutrition and wellness delivery
The landscape of personalized retail nutrition and wellness is being reshaped by several transformative shifts that extend across technology, consumer behavior, regulation, and distribution. Advances in digital health capabilities-ranging from wearable sensing to cloud-native analytics-are enabling richer, continuous streams of consumer data, which in turn support more precise, contextualized recommendations and adaptive product formulations. Concurrently, consumers are demonstrating higher expectations for transparency, ethical sourcing, and clinically grounded claims, prompting brands to invest in verifiable evidence and clearer communication.
Regulatory scrutiny and evolving standards for health-related claims are also prompting strategic recalibrations. Firms are prioritizing compliance pathways, scientific partnerships, and robust labeling practices to maintain consumer trust while minimizing legal and reputational risk. Distribution is fragmenting and converging at once: direct-to-consumer digital channels are coexisting with traditional retail footprints and health care integration, creating hybrid models that emphasize convenience, professional oversight, and omnichannel fulfillment.
Taken together, these shifts create both opportunity and complexity. Companies that can operationalize data responsibly, demonstrate clinical validity, and orchestrate omnichannel distribution will be better positioned to scale personalized offerings in a way that delivers meaningful health outcomes and durable commercial returns.
How the cumulative effects of recent United States tariff changes are reshaping sourcing, supply chain resilience, and product strategy across personalized wellness offerings
Recent tariff developments in the United States have introduced a compound set of operational, sourcing, and pricing considerations for companies engaged in personalized retail nutrition and wellness. Tariff adjustments affecting imported ingredients, finished supplements, and certain electronic components used in fitness trackers and diagnostic devices have increased the complexity of global supply decisions. As a result, many organizations are reassessing supplier footprints, inventory strategies, and regional manufacturing options to mitigate cost volatility and preserve margin integrity.
Beyond direct cost implications, tariff measures have ripple effects on product formulation choices and the sourcing of clinically validated inputs. Procurement teams are evaluating domestic and nearshore suppliers to reduce exposure to trade disruptions, while product development functions are prioritizing ingredient flexibility to enable rapid substitution when necessary. Logistics and lead-time management have become central to commercial planning, with inventory buffers and alternative routing options incorporated to maintain service levels for subscription and replenishment models.
In addition, tariffs are accelerating strategic conversations about vertical integration and partnerships. Companies with trading agility and diversified sourcing are better able to sustain retail price stability and preserve customer trust. Ultimately, the cumulative impact of tariff shifts underscores the need for dynamic supply strategies, closer supplier relationships, and scenario-based planning to ensure continuity of personalized offerings in a rapidly changing trade environment.
Detailed segmentation insights that connect product typologies, distribution pathways, sales models, and diverse end-user cohorts to inform targeted commercial strategies
Segmentation insights reveal distinct demand signals and operational priorities across the product, distribution, sales, and end-user dimensions that define the personalized nutrition and wellness landscape. By product type, offerings range from fitness trackers that capture behavioral and physiological signals to meal services that deliver convenience and dietary adherence; nutrigenomics tests that translate genetic markers into tailored dietary guidance; nutritional counseling that connects clinical expertise with behavior change strategies; and supplements offered in capsules, liquids, and powders that address concentrated nutritional needs. Each product category carries different validation requirements, packaging needs, and return-to-consumer workflows, which influence go-to-market planning and customer onboarding.
Distribution patterns are equally varied, spanning online retailers that enable personalized configuration and recurring fulfillment; pharmacies and drug stores that offer healthcare-adjacent credibility and point-of-care accessibility; specialty stores that curate targeted assortments; and supermarkets and hypermarkets that deliver scale and impulse accessibility. The chosen channel affects discovery mechanics, promotional cadence, and fulfillment complexity, and therefore must align with the product’s evidence requirements and consumer expectations.
Sales models further differentiate revenue lifecycles and engagement intensity, encompassing one-time purchases for discrete products, pay-per-use arrangements for on-demand testing or services, and subscriptions that support ongoing adherence and replenishment. Finally, end-user segmentation spans fitness centers that value integration with coaching and class experiences, healthcare and wellness centers that emphasize clinical oversight, and individual consumers whose needs cluster around general wellness, sports nutrition, or weight management. Understanding these intersecting segments enables precise positioning, tailored service design, and investment prioritization across product development and channel partnerships.
Region-specific strategic considerations for scaling personalized nutrition and wellness offerings across Americas, Europe, Middle East & Africa, and Asia-Pacific markets
Regional dynamics exert a powerful influence on product adoption, regulatory posture, and partnership opportunities across the global personalized nutrition and wellness ecosystem. In the Americas, consumer appetite for convenience and evidence-based personalization is high, allied with a sophisticated digital payments and fulfillment infrastructure that supports subscription and direct-to-consumer models. Regulatory and reimbursement pathways are complex and vary by jurisdiction, prompting firms to adopt phased rollouts and localized clinical validation approaches.
In Europe, the Middle East & Africa, harmonized regulatory frameworks across many European markets and high consumer expectations for sustainability and ethical sourcing shape product claims and packaging choices. Meanwhile, emerging markets across the region present growth opportunities driven by rising health awareness and increasing investment in retail infrastructure, but they require tailored pricing strategies and culturally relevant product formulations. Supply chain resilience and compliance with cross-border data rules are important considerations for companies planning multi-country deployments.
Across Asia-Pacific, rapid digital adoption and a strong retail technology ecosystem enable fast consumer feedback loops and agile personalization features. Markets in this region often combine high receptivity to nutraceuticals and wellness services with distinct local ingredient preferences and regulatory regimes. Strategic partnerships with regional distributors and local clinical partners can accelerate acceptance and ensure that offerings align with both consumer tastes and regulatory expectations. Across all regions, successful entrants balance global best practices with rigorous local adaptation.
Competitive and partnership dynamics that drive differentiation through clinical validation, data capabilities, and integrated retail-to-care execution across the ecosystem
Competitive dynamics in personalized retail nutrition and wellness are shaped by a mix of specialty innovators, established consumer brands extending into personalization, and service providers that bridge clinical expertise with retail execution. Leading players differentiate through proprietary data assets, clinically validated algorithms, and tightly managed supply chains that ensure product consistency and trust. Strategic partnerships between technology providers and clinical institutions are becoming more common, enabling faster evidence generation and enhanced credibility for consumer-facing claims.
Mergers and alliances are also reshaping capability sets, with companies seeking to combine diagnostic insights, behavioral engagement platforms, and distribution reach in order to offer end-to-end personalized solutions. At the same time, niche specialists continue to command attention by focusing on specific use cases-such as athletic performance, metabolic health, or age-related nutrition-where deep domain expertise and targeted formulations deliver measurable benefits. Operational excellence in regulatory compliance, data privacy, and quality control remains a sustained differentiator, particularly as scrutiny on health claims intensifies.
In this competitive environment, incumbents that pair robust clinical validation with seamless retail experiences will sustain consumer trust and long-term engagement, while new entrants that can move quickly to demonstrate efficacy and differentiate through service integration will capture emerging segments of demand.
Actionable recommendations for leaders to align clinical validation, supply resilience, and omnichannel execution for scalable personalized nutrition and wellness offerings
Industry leaders seeking to capture value in personalized retail nutrition and wellness should prioritize a set of actionable initiatives that align clinical rigor with commercial execution. First, invest in modular product architectures and ingredient sourcing flexibility to enable rapid adaptation to supply disruptions and regulatory shifts. Second, establish partnerships with accredited clinical and research institutions to strengthen evidence generation and to support transparent consumer communication about efficacy and safety. Third, design omnichannel fulfillment pathways that maintain consistent consumer experiences across online, pharmacy, specialty, and supermarket touchpoints while optimizing for customer lifetime engagement.
Additionally, build data governance frameworks that ensure privacy, interoperability, and analytic integrity so that personalization algorithms can be validated and audited. Operationalize subscription and replenishment models with frictionless onboarding and clearly communicated outcomes to minimize churn and maximize adherence. Finally, allocate resources to scenario-based supply chain planning and tariff impact mitigation, embracing nearshoring and multi-sourcing strategies where appropriate to preserve margin and continuity. Taken together, these actions will strengthen resilience, accelerate adoption, and enhance the credibility of personalized offerings in a competitive landscape.
Transparent research methodology combining interviews, clinical literature review, regulatory analysis, and operational scenario assessment to validate actionable insights
The research approach integrates qualitative and quantitative evidence streams to produce an evidence-informed synthesis of industry dynamics, consumer behavior, and operational considerations. Primary engagements include structured interviews with industry executives, clinical advisers, and distribution partners to capture firsthand perspectives on adoption barriers, pricing sensitivities, and channel economics. Secondary inputs encompass peer-reviewed clinical literature, product labeling and regulatory guidance, patent filings, and publicly available company disclosures to triangulate technical claims and capability sets.
Analytical steps emphasize cross-validation and scenario analysis: findings from interviews are compared with published clinical evidence and regulatory documentation to assess claim robustness, while supply chain observations are mapped against trade data and logistics indicators to evaluate resilience. Where applicable, case studies illustrate how different business models-such as subscription versus one-time purchase-affect customer retention and fulfillment complexity. Transparency in source attribution and methodological limitations is maintained throughout the research so that readers can understand evidence strength and boundary conditions for the insights provided.
Concluding synthesis emphasizing the necessity of clinical credibility, supply resilience, and omnichannel execution to realize personalization-driven value in retail wellness
The personalized retail nutrition and wellness domain sits at an intersection of science, retail, and consumer behavior, presenting substantial opportunity alongside operational complexity. Organizations that successfully bridge clinical validation with frictionless retail experiences will build durable consumer trust and sustained engagement. Conversely, those that underinvest in evidence, data governance, or supply resilience risk reputational exposure and commercialization friction.
Looking ahead, success will hinge on the ability to integrate multidimensional capabilities-robust ingredient supply networks, validated personalization algorithms, trusted clinical partnerships, and seamless omnichannel fulfillment. Companies that adopt flexible product architectures, prioritize transparent claims supported by clinical input, and design subscription and replenishment mechanics for adherence will be best positioned to meet evolving consumer expectations. The path to durable growth depends not only on innovation, but on disciplined execution across regulatory, operational, and customer-experience domains.
Please Note: PDF & Excel + Online Access - 1 Year
Table of Contents
188 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Integration of AI-driven nutritional profiling tools into e-commerce platforms for personalized supplement recommendations
- 5.2. Expansion of subscription-based personalized meal kit services leveraging consumer DNA and microbiome analysis for customized diets
- 5.3. Retail biometric scanning kiosks enabling in-store customers to receive real-time customized nutrition advice based on health metrics
- 5.4. Partnerships between fitness wearables and grocery retailers to offer tailored product suggestions aligned with user activity data
- 5.5. Growth of adaptive retail loyalty programs offering personalized wellness product bundles based on purchase history and health goals
- 5.6. Implementation of virtual nutrition coaches in mobile retail apps using behavioral analytics to enhance customer engagement
- 5.7. Emergence of blockchain-backed ingredient transparency platforms allowing consumers to verify personalized supplement formulations
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Personalized Retail Nutrition & Wellness Market, by Product Type
- 8.1. Fitness Trackers
- 8.2. Meal Services
- 8.3. Nutrigenomics Tests
- 8.4. Nutritional Counseling
- 8.5. Supplements
- 8.5.1. Capsules
- 8.5.2. Liquids
- 8.5.3. Powders
- 9. Personalized Retail Nutrition & Wellness Market, by Sales Model
- 9.1. One-time Purchase
- 9.2. Pay-per-use
- 9.3. Subscription
- 10. Personalized Retail Nutrition & Wellness Market, by Distribution Channel
- 10.1. Online Retailers
- 10.2. Pharmacies & Drug Stores
- 10.3. Specialty Stores
- 10.4. Supermarkets & Hypermarkets
- 11. Personalized Retail Nutrition & Wellness Market, by End-user
- 11.1. Fitness Centers
- 11.2. Healthcare & Wellness Centers
- 11.3. Individual Consumers
- 11.3.1. General Wellness
- 11.3.2. Sports Nutrition
- 11.3.3. Weight Management
- 12. Personalized Retail Nutrition & Wellness Market, by Region
- 12.1. Americas
- 12.1.1. North America
- 12.1.2. Latin America
- 12.2. Europe, Middle East & Africa
- 12.2.1. Europe
- 12.2.2. Middle East
- 12.2.3. Africa
- 12.3. Asia-Pacific
- 13. Personalized Retail Nutrition & Wellness Market, by Group
- 13.1. ASEAN
- 13.2. GCC
- 13.3. European Union
- 13.4. BRICS
- 13.5. G7
- 13.6. NATO
- 14. Personalized Retail Nutrition & Wellness Market, by Country
- 14.1. United States
- 14.2. Canada
- 14.3. Mexico
- 14.4. Brazil
- 14.5. United Kingdom
- 14.6. Germany
- 14.7. France
- 14.8. Russia
- 14.9. Italy
- 14.10. Spain
- 14.11. China
- 14.12. India
- 14.13. Japan
- 14.14. Australia
- 14.15. South Korea
- 15. Competitive Landscape
- 15.1. Market Share Analysis, 2024
- 15.2. FPNV Positioning Matrix, 2024
- 15.3. Competitive Analysis
- 15.3.1. Abbott Laboratories
- 15.3.2. Advanced Orthomolecular Research
- 15.3.3. Amway Corporation
- 15.3.4. Archer Daniels Midland Company
- 15.3.5. Bactolac Pharmaceuticals, Inc.
- 15.3.6. Bayer AG
- 15.3.7. Cargill, Incorporated
- 15.3.8. Danone S.A.
- 15.3.9. Dymatize Enterprises LLC
- 15.3.10. FANCL Corporation
- 15.3.11. General Mills, Inc.
- 15.3.12. Glanbia PLC
- 15.3.13. GlaxoSmithKline PLC
- 15.3.14. Herbalife Nutrition Ltd.
- 15.3.15. Himalaya Wellness Company
- 15.3.16. International Flavors & Fragrances Inc.
- 15.3.17. Koninklijke DSM N.V.
- 15.3.18. Matsun Nutrition
- 15.3.19. Nestlé S.A.
- 15.3.20. Otsuka Holdings Co. Ltd.
- 15.3.21. Pfizer, Inc.
- 15.3.22. Reckitt Benckiser Group plc
- 15.3.23. Suntory Holdings Limited
- 15.3.24. The Procter & Gamble Company
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
